Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2017

Open Access 01-12-2017 | Research article

Associated factors with functional disability and health-related quality of life in Chinese patients with gout: a case-control study

Authors: Ting Fu, Haixia Cao, Rulan Yin, Lijuan Zhang, Qiuxiang Zhang, Liren Li, Zhifeng Gu

Published in: BMC Musculoskeletal Disorders | Issue 1/2017

Login to get access

Abstract

Background

Gout is a painful, inflammatory disease that may cause decreased function and health-related quality of life (HRQoL). Limited study did not take the influence of gout characteristics and anxiety on HRQoL into consideration and there are no studies associated with functional disability in individuals with gout from China. This study aims to investigate the related factors of functional disability and HRQoL in gout patients recruited from China.

Methods

A total of 226 consecutive gout patients and 232 age- and gender-matched healthy individuals were involved in the study. A series of questionnaires (the Short Form 36 health survey, the Patient Health Questionnaire, the Generalized Anxiety Disorder questionnaire, the 10 cm Visual Analog Scale, and the Health Assessment Questionnaire-Disability Index) were applied. Blood samples were taken to examine the level of serum uric acid. Independent samples t-tests, Chi square tests, U test, Spearman rank correlation, logistic regression modeling, and linear regression were used to analyze the data.

Results

After adjusted demographic variables, individuals with gout have poorer HRQoL compared to healthy controls. Univariate tests presented that patients with functional disability had longer disease duration, more frequent flares/last year, more severe total pain, more number of tophi, higher degree of depression and anxiety, with a trend toward diabetes, the treatment of colchicine and corticosteroids use, compared to patients without functional disability. Meanwhile, place of residence, hypertension, DM, disease duration, cardiovascular disease, number of flares/last year, total pain, more number of tophi, presence of tender joints, depression, anxiety, currently using colchicine and corticosteroids were correlated significantly with HRQoL. Additionally, multiple regression analysis identified severe pain, depression, and colchicine use as predictors of functional disability. Cardiovascular disease, total pain, number of flares/last year, presence of tender joints, depression, anxiety, colchicine and corticosteroids use contributed to low HRQoL.

Conclusions

After adjusted demographic variables, gout subjects have poorer HRQoL compared to healthy controls. Chinese gout population experiencing poor HRQoL and functional disability were likely to suffer from gout-related features and psychological problems. The results underscore the need of effective interventions including psychological nursing and appropriate treatment approaches to reduce their functional disability and improve their HRQoL.
Literature
1.
Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74(4):661–7.CrossRefPubMed
2.
Smith EU, Diaz-Torne C, Perez-Ruiz F, March LM. Epidemiology of gout: an update. Best Pract Res Clin Rheumatol. 2010;24(6):811–27.CrossRefPubMed
3.
Roddy E, Choi HK. Epidemiology of gout. Rheum Dis Clin N Am. 2014;40(2):155–75.CrossRef
4.
Scire CA, Manara M, Cimmino MA, Govoni M, Salaffi F, Punzi L, Monti MC, Carrara G, Montecucco C, Matucci-Cerinic M, et al. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis research & therapy. 2013;15(5):R101.CrossRef
5.
Changchien TC, Yen YC, Lin CL, Lin MC, Liang JA, Kao CH. High risk of depressive disorders in patients with gout: a Nationwide population-based cohort study. Medicine. 2015;94(52):e2401.CrossRefPubMedPubMedCentral
6.
Branco JC, Rodrigues AM, Gouveia N, Eusebio M, Ramiro S, Machado PM, da Costa LP, Mourao AF, Silva I, Laires P, et al. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey. RMD open. 2016;2(1):e000166.CrossRefPubMedPubMedCentral
7.
Hirsch JD, Terkeltaub R, Khanna D, Singh J, Sarkin A, Shieh M, Kavanaugh A, Lee SJ. Gout disease-specific quality of life and the association with gout characteristics. Patient Relat Outcome Meas. 2010;2010:1–8.CrossRefPubMed
8.
Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008;67(9):1310–6.CrossRefPubMed
9.
Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, Edwards L, Kawata AK, Frank L, Waltrip R, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol. 2009;36(5):1041–8.CrossRefPubMed
10.
Singh JA, Bharat A, Khanna D, Aquino-Beaton C, Persselin JE, Duffy E, Elashoff D, Khanna PP. Racial differences in health-related quality of life and functional ability in patients with gout. Rheumatology. 2017;56(1):103–12.CrossRefPubMed
11.
Khanna PP, Nuki G, Bardin T, Tausche AK, Forsythe A, Goren A, Vietri J, Khanna D. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional survey. Health Qual Life Outcomes. 2012;10:117.CrossRefPubMedPubMedCentral
12.
Lee SJ, Hirsch JD, Terkeltaub R, Khanna D, Singh JA, Sarkin A, Kavanaugh A. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology. 2009;48(5):582–6.CrossRefPubMedPubMedCentral
13.
Lopez Lopez CO, Lugo EF, Alvarez-Hernandez E, Pelaez-Ballestas I, Burgos-Vargas R, Vazquez-Mellado J. Severe tophaceous gout and disability: changes in the past 15 years. Clin Rheumatol. 2017;36(1):199–204.CrossRefPubMed
14.
Prior JA, Mallen CD, Chandratre P, Muller S, Richardson J, Roddy E. Gout characteristics associate with depression, but not anxiety, in primary care: baseline findings from a prospective cohort study. Joint Bone Spine. 2016;83(5):553–8.CrossRefPubMed
15.
Mewes R, Rief W, Kenn K, Ried J, Stenzel N. Psychological predictors for health-related quality of life and disability in persons with chronic obstructive pulmonary disease (COPD). Psychol Health. 2016;31(4):470–86.CrossRefPubMed
16.
Wan SW, He HG, Mak A, Lahiri M, Luo N, Cheung PP, Wang W. Health-related quality of life and its predictors among patients with rheumatoid arthritis. Appl Nurs Res. 2016;30:176–83.CrossRefPubMed
17.
Chandratre P, Mallen C, Richardson J, Rome K, Bailey J, Gill R, Hider S, Mason J, Mayson Z, Muller S, et al. Prospective observational cohort study of health related quality of life (HRQOL), chronic foot problems and their determinants in gout: a research protocol. BMC Musculoskelet Disord. 2012;13:219.CrossRefPubMedPubMedCentral
18.
Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820.PubMedPubMedCentral
19.
Bao KJ, Liu Y, Zhou LN, Chen B, Endocrinology DO, Hospital S. Health-related quality of life and influencing factors in patients with chronic gouty arthritis. Hainan Medical Journal. 2016;27(23):3930-932.
20.
Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, TF Y. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20(3):895–900.CrossRefPubMed
21.
Alvarez-Hernandez E, Pelaez-Ballestas I, Vazquez-Mellado J, Teran-Estrada L, Bernard-Medina AG, Espinoza J, Aceves-Avila FJ, Goycochea-Robles MV, Garza M, Ventura L, et al. Validation of the health assessment questionnaire disability index in patients with gout. Arthritis Rheum. 2008;59(5):665–9.CrossRefPubMed
22.
Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N. The health assessment questionnaire disability index is a valid measure of physical function in gout. Clin Exp Rheumatol. 2008;26(4):620–6.PubMed
23.
Koh ET, Seow A, Pong LY, Koh WH, Chan L, Howe HS, Lim TH, Low CK. Cross cultural adaptation and validation of the Chinese health assessment questionnaire for use in rheumatoid arthritis. J Rheumatol. 1998;25(9):1705–8.PubMed
24.
Singh JA, Taylor WJ, Simon LS, Khanna PP, Stamp LK, McQueen FM, Neogi T, Gaffo AL, Becker MA, MacDonald PA, et al. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011;38(7):1452–7.CrossRefPubMed
25.
Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis. 2010;69(1):48–53.CrossRefPubMed
26.
He X, Li C, Jie Q, Cui H. Reliability and validity of a generalized anxiety disorder scale in general hospital outpatients. Shanghai Arch Psychiatry. 2010;22:200–3.
27.
Bian CD, Xiao-Yan HE, Qian J, Wen-Yuan WU, Chun-Bo LI. The reliability and validity of a modified patient health questionnaire for screening depressive syndrome in general hospital outpatients. Shanghai Arch Psychiatry. 2009;30:1360–140.
28.
29.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.CrossRefPubMed
30.
Emery P, Kavanaugh A, Bao Y, Ganguli A, Mulani P. Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis? Ann Rheum Dis. 2015;74(12):2165–74.CrossRefPubMed
31.
Li L, Wang HM, Shen Y. Chinese SF-36 health survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health. 2003;57(4):259–63.CrossRefPubMedPubMedCentral
32.
Spaetgens B, Tran-Duy A, Wijnands JM, van der Linden S, Boonen A. Health and Utilities in Patients with Gout under the Care of a Rheumatologist. Arthritis Care Res (Hoboken). 2015;67(8):1128–36.CrossRefPubMed
33.
Chandratre P, Mallen CD, Roddy E, Liddle J, Richardson J. "You want to get on with the rest of your life": a qualitative study of health-related quality of life in gout. Clin Rheumatol. 2016;35(5):1197–205.CrossRefPubMed
34.
Gregg EW, Mangione CM, Cauley JA, Thompson TJ, Schwartz AV, Ensrud KE, Nevitt MC. Diabetes and incidence of functional disability in older women. Diabetes Care. 2002;25(1):61–7.CrossRefPubMed
35.
Zagozdzon P, Kolarzyk E, Marcinkowski JT. Quality of life and rural place of residence in polish women - population based study. Ann Agric Environ Med. 2011;18(2):429–32.PubMed
36.
Lahana E, Pappa E, Niakas D. The impact of ethnicity, place of residence and socioeconomic status on health-related quality of life: results from a Greek health survey. Int J Public Health. 2010;55(5):391–400.CrossRefPubMed
37.
Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology. 2007;46(9):1441–4.CrossRefPubMed
38.
Hsu NW, Tsao HM, Chen HC, Chou P. Anxiety and depression mediate the health-related quality of life differently in patients with cardiovascular disease and stroke-preliminary report of the Yilan study: a population-based community health survey. PLoS One. 2014;9(9):e107609.CrossRefPubMedPubMedCentral
39.
EQ W, Forsythe A, Guerin A, AP Y, Latremouille-Viau D, Tsaneva M. Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy. Am J Ther. 2012;19(6):e157–66.CrossRef
40.
EQ W, Patel PA, Mody RR, AP Y, Cahill KE, Tang J, Krishnan E. Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? J Rheumatol. 2009;36(5):1032–40.CrossRef
41.
Rome K, Stewart S, Vandal AC, Gow P, McNair P, Dalbeth N. The effects of commercially available footwear on foot pain and disability in people with gout: a pilot study. BMC Musculoskelet Disord. 2013;14:278.CrossRefPubMedPubMedCentral
42.
Khanna PP, Gladue HS, Singh MK, FitzGerald JD, Bae S, Prakash S, Kaldas M, Gogia M, Berrocal V, Townsend W, et al. Treatment of acute gout: a systematic review. Semin Arthritis Rheum. 2014;44(1):31–8.CrossRefPubMed
43.
44.
Ciccarelli F, De Martinis M, Ginaldi L. Glucocorticoids in patients with rheumatic diseases: friends or enemies of bone? Curr Med Chem. 2015;22(5):596–603.CrossRefPubMed
45.
Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, Zink A, Buttgereit F. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009;68(7):1119–24.CrossRefPubMed
46.
Derijk RH, Van LN, Klok MD, Zitman FG. Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health. Eur J Pharmacol. 2008;585(2–3):492–501.CrossRefPubMed
47.
Shen B, Feng G, Tang W, Huang X, Yan H, He Y, Chen W, Da Z, Liu H, Gu Z. The quality of life in Chinese patients with systemic lupus erythematosus is associated with disease activity and psychiatric disorders: a path analysis. Clin Exp Rheumatol. 2014;32(1):101–7.PubMed
48.
Xu X, Shen B, Zhang A, Liu J, Da Z, Liu H, Gu Z. Anxiety and depression correlate with disease and quality-of-life parameters in Chinese patients with ankylosing spondylitis. Patient Prefer Adherence. 2016;10:879–85.CrossRefPubMedPubMedCentral
49.
Kronisch C, McLernon DJ, Dale J, Paterson C, Ralston SH, Reid DM, Tierney A, Harvie J, McKay N, Wilson HE, et al. Brief report: predicting functional disability: one-year results from the Scottish early rheumatoid arthritis inception cohort. Arthritis Rheumatol. 2016;68(7):1596–602.CrossRefPubMed
Metadata
Title
Associated factors with functional disability and health-related quality of life in Chinese patients with gout: a case-control study
Authors
Ting Fu
Haixia Cao
Rulan Yin
Lijuan Zhang
Qiuxiang Zhang
Liren Li
Zhifeng Gu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2017
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-017-1787-7

Other articles of this Issue 1/2017

BMC Musculoskeletal Disorders 1/2017 Go to the issue

Research article

Interobserver and intraobserver agreement of ligamentous injuries on conventional MRI after simple elbow dislocation

Research article

Is coracohumeral distance associated with pain-function, and shoulder range of movement, in chronic anterior shoulder pain?

Research article

Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: a report from the International consensus on outcome measures in TJR trials (I-COMiTT) group

Research article

Total knee Arthroplasty: risk factors for allogeneic blood transfusions in the South Asian population

Research article

A new multiple trauma model of the mouse

Research article

Does structural leg-length discrepancy affect postural control? Preliminary study